Found 6 matching trials
COVID-19 Subcutaneously and Orally Administered Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines PHASE1 This is a phase 1/2 study in adult healthy subjects that have previously be...
Show More Location
Multiple Locations
Learn More & Join Trial
COVID-19 Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines PHASE1 This is a phase 1/2 study in adult healthy subjects that have previously be...
Show More Location
Multiple Locations
Learn More & Join Trial
COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers PHASE1 This is a phase 1b, open-label study in adult healthy subjects. This clinic...
Show More Location
Chan Soon - Shiong Institute for Medicine
Learn More & Join Trial
COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral Platform in Healthy South African Adults PHASE1 This is a phase 1b, open-label study in adult healthy participants. This cl...
Show More Location
Khayelitsha Clinical Research Site
Learn More & Join Trial
COVID-19 Oral and Subcutaneous Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenovirus Platform in Healthy Volunteers in USA PHASE1 This is a phase 1b, open-label study in adult healthy subjects. This clinic...
Show More Location
Chan Soon - Shiong Institute for Medicine
Learn More & Join Trial
A 2nd Generation E1/E2B/E3-Deleted Adenoviral COVID-19 Vaccine: The TCELL VACCINE TRIAL PHASE2 This is a phase 2/3, multicenter, randomized, placebo-controlled, observer-...
Show More Location
Hoag Memorial Hospital Presbyterian
Learn More & Join Trial